UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9/A (RULE 14d-101...
A New Choice in Clinical Resourcing and Talent Management PRINCETON, N.J., March 4 /PRNewswire-FirstCall/ -- PharmaNet Development Group, Inc...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9/A (RULE...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________ FORM 8-K ______________ CURRENT...
PRINCETON, N.J., Feb. 25 /PRNewswire-FirstCall/ -- PharmaNet Development Group, Inc. (the "Company") (NASDAQ:PDGI), a leading provider of...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO/A Tender Offer Statement...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO/A...
PRINCETON, N.J., Feb. 18 /PRNewswire-FirstCall/ -- PharmaNet Development Group, Inc. (the "Company") (NASDAQ:PDGI), a leading provider of...
Securities and Exchange Commission Washington, D. C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 4) PharmaNet...
OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response 10.4 UNITED STATES SECURITIES AND...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 Pharmanet...
OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response………11...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.